150 related articles for article (PubMed ID: 19544141)
21. Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-cell lymphoma.
Richardson SK; McGinnis KS; Shapiro M; Lehrer MS; Kim EJ; Vittorio CC; Junkins Hopkins JM; Rook AH
J Cutan Med Surg; 2003; 7(4 Suppl):8-12. PubMed ID: 12958701
[No Abstract] [Full Text] [Related]
22. Treatment with alemtuzumab in a case of refractory primary cutaneous CD30-negative CD8-positive cytotoxic large T-cell lymphoma.
Gutierrez A; Rodriguez J; Ramos R; Gines J; Sampol A; Galmes B; Besalduch J
Eur J Haematol; 2004 May; 72(5):377-8. PubMed ID: 15059077
[No Abstract] [Full Text] [Related]
23. [Autologous hematopoietic stem cell transplantation followed by oral bexarotene in a patient with advanced mycosis fungoides].
Pérez-Barrio S; Izu R; García-Ruiz JC; Acebo E; Martínez de Lagrán Z; Díaz-Pérez JL
Actas Dermosifiliogr; 2008 Sep; 99(7):560-4. PubMed ID: 18682170
[TBL] [Abstract][Full Text] [Related]
24. Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma.
Shehan JM; Kalaaji AN; Markovic SN; Ahmed I
J Am Acad Dermatol; 2004 Jul; 51(1):103-10. PubMed ID: 15243534
[TBL] [Abstract][Full Text] [Related]
25. Leukaemic presentation of angioimmunoblastic T-cell lymphoma.
Lin KW; Lee YS; Phipps C
Br J Haematol; 2014 Sep; 166(6):808. PubMed ID: 24974735
[No Abstract] [Full Text] [Related]
26. Primary cutaneous anaplastic large cell lymphoma with rapid liver infiltration after spontaneous resolution of the primary lesion.
Kume M; Kiyohara E; Aoyama R; Hayashi M; Morikawa Y; Maeda T; Tanemura A; Wataya-Kaneda M; Katayama I; Fujimoto M
J Dermatol; 2020 May; 47(5):e190-e191. PubMed ID: 32141106
[No Abstract] [Full Text] [Related]
27. Primary cutaneous large B-cell non-Hodgkin lymphoma in first-degree relatives.
Čolović M; Vidovic A; Čolović N; Peruničić-Jovanović M; Tomin D
Biomed Pharmacother; 2012 Sep; 66(6):425-7. PubMed ID: 22898082
[TBL] [Abstract][Full Text] [Related]
28. Complete remission of refractory disseminated NK/T cell lymphoma with brentuximab vedotin and bendamustine.
Poon LM; Kwong YL
Ann Hematol; 2016 Apr; 95(5):847-9. PubMed ID: 26931114
[No Abstract] [Full Text] [Related]
29. [CD30 (Ki-1+) anaplastic large cell lymphomas].
Bagot M; Wechsler J; Cosnes A; Haioun C; Divine M; Gaulard P; Henni T; Revuz J
Ann Dermatol Venereol; 1989; 116(11):881-3. PubMed ID: 2482686
[No Abstract] [Full Text] [Related]
30. Folliculotropic mycosis fungoides and a leonine clinical appearance of the face.
Ito T; Yamamoto T; Matsumoto Y; Wakamatsu J; Kato Y; Tsuboi R
Dermatol Online J; 2008 Sep; 14(9):6. PubMed ID: 19061588
[TBL] [Abstract][Full Text] [Related]
31. Primary cutaneous CD30 (Ki-1)-positive non-anaplastic B-cell lymphoma.
Herrera E; Gallardo M; Bosch R; Cabra B; Aneri V; Sánchez P
J Cutan Pathol; 2002 Mar; 29(3):181-4. PubMed ID: 11972717
[TBL] [Abstract][Full Text] [Related]
32. Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients.
Bekkenk MW; Vermeer MH; Geerts ML; Noordijk EM; Heule F; van Voorst Vader PC; van Vloten WA; Meijer CJ; Willemze R
J Clin Oncol; 1999 Aug; 17(8):2471-8. PubMed ID: 10561311
[TBL] [Abstract][Full Text] [Related]
33. Non-Hodgkin's lymphoma (diffuse large B cell lymphoma).
Copson E
Clin Evid; 2005 Jun; (13):1-18. PubMed ID: 16135258
[No Abstract] [Full Text] [Related]
34. [Cervicofacial cellulitis revealing cutaneous lymphomas].
Benbouzid MA; Bencheikh R; Benhammou A; El Edghiri H; Boulaich M; Essakali L; Kzadri M
Rev Stomatol Chir Maxillofac; 2007 Jun; 108(3):228-30. PubMed ID: 17399753
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
[TBL] [Abstract][Full Text] [Related]
36. Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab.
Grange F; Maubec E; Bagot M; Beylot-Barry M; Joly P; Dalle S; Delaporte E; Dereure O; Bachelez H; Vergier B; Petrella T; D'Incan M
Arch Dermatol; 2009 Mar; 145(3):329-30. PubMed ID: 19289772
[No Abstract] [Full Text] [Related]
37. Response of CD30+ large cell lymphoma of skin to bexarotene.
Keun YK; Woodruff R; Sangueza O
Leuk Lymphoma; 2002 May; 43(5):1153-4. PubMed ID: 12148901
[TBL] [Abstract][Full Text] [Related]
38. Regression of CD30+ cutaneous anaplastic large-cell lymphoma with denileukin diftitox.
Dao H; Barr PM; Honda K
J Am Acad Dermatol; 2011 Jun; 64(6):e123-5. PubMed ID: 21571160
[No Abstract] [Full Text] [Related]
39. Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: report of the Dutch Cutaneous Lymphoma Group.
Melchers RC; Willemze R; Bekkenk MW; de Haas ERM; Horvath B; van Rossum MM; Sanders CJG; Veraart JCJM; Vermeer MH; Quint KD
Br J Dermatol; 2018 Sep; 179(3):724-731. PubMed ID: 29494757
[TBL] [Abstract][Full Text] [Related]
40. Posttransplant primary cutaneous Ki-1 (CD30)+/CD56+ anaplastic large cell lymphoma.
Kim HK; Jin SY; Lee NS; Won JH; Park HS; Yang WI
Arch Pathol Lab Med; 2004 Aug; 128(8):e96-9. PubMed ID: 15270625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
